New prenylchalcones targeting the MDM2-p53 protein-protein interaction: synthesis and evaluation of antitumor activity Abstract:
Among the chemical world of flavonoids, prenylated derivatives have been attracting the attention because of the myriad of their biological activities, with chalcones being widely reported for their antitumor activity against a variety of tumor cell lines. In fact, it has been demonstrated that isoprenylation of flavonoids significantly increased their growth inhibitory effect on human tumor cell lines. A series of prenylchalcones was synthesized and evaluated for the ability to inhibit the MDM2-p53 interaction using a yeast-based assay. The capacity of all synthesized prenylchalcones and their non-prenylated precursors to inhibit the growth of human colon tumor HCT116 cells was evaluated and compared. The overall results led to the identification of a hit compound, which behaved as potential inhibitor of the MDM2-p53 interaction in yeast, and showed improved cytotoxicity against human tumor cells expressing wild-type p53. In HCT116 cancer cells, it was also shown that the growth inhibitory effect of this prenylchalcone was associated with the induction of cell cycle arrest, and apoptosis. 2.7 ± 0.3 2f 1.9 ± 0.2 1g
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Among the compounds revealed by the yeast assay as potential p53-activating agents, the compound 2e exhibited the lowest IC 50 value (2.1 ± 0.1 µM) .
Colony formation assay for HCT116 cells treated with 2e (or DMSO only) for 11 days; images correspond to a representative experiment of three; graphs represent mean ± SEM of three independent experiments; values significantly different from DMSO are indicated: **P < 0.01; ***P <0.001. 
Cytotoxicity of compound 2e against HCT116 cells in the colony formation assay
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